Timedora
Free Practice Quiz Question List

Short-Acting β₂-Agonists Online Quiz Questions

Use this free practice quiz with 20 questions to review Short-Acting β₂-Agonists, test your knowledge, and prepare for your next test or exam.

20 questions
01
Choose one
1 point

How do short-acting β₂-agonists such as albuterol relieve bronchospasm?

  1. A

    They stimulate β₂-adrenergic receptors in airway smooth muscle, increasing cyclic AMP and relaxing the muscle.

  2. B

    They block muscarinic receptors, reducing airway secretions.

  3. C

    They activate glucocorticoid receptors and suppress airway inflammation.

  4. D

    They inhibit β₂-adrenergic receptors, tightening airway smooth muscle.

02
Choose all
1 point

Select all statements about short-acting β₂-agonists that are correct.

  1. A

    They are inhaled by pMDI, preferably with a spacer, or by nebulizer.

  2. B

    They are routinely given as oral tablets because inhaled delivery is ineffective.

  3. C

    Tremor, nervousness, palpitations, and tachycardia are common dose-related effects.

  4. D

    With frequent or high-dose treatment, assess heart rate and consider ECG and potassium; consider lactate if unexplained acidosis or persistent tachypnea occurs.

  5. E

    Repeated high doses increase serum potassium and reliably prevent arrhythmias.

03
True or false
1 point

Short-acting β₂-agonists are first-line reliever bronchodilators in acute asthma and are also initial bronchodilators in COPD exacerbations.

  1. A

    True

  2. B

    False

04
Written response
1 point

Name one short-acting β₂-agonist listed as an example.

05
Fill in the blank
1 point

Short-acting β₂-agonists stimulate receptors in airway smooth muscle, increasing and relaxing the muscle.

06
Open ended
1 point

Explain how short-acting β₂-agonists work and are used in acute asthma and COPD exacerbations. Include their administration, important adverse effects, and monitoring.

07
Choose one
1 point

A patient experiencing an acute exacerbation cannot use an inhaler effectively. Which inhaled delivery method may be useful for a short-acting β₂-agonist?

  1. A

    Switch to an oral β₂-agonist, because inhaled treatment cannot relieve acute bronchospasm.

  2. B

    Use a nebulizer, which may be useful when the patient cannot use an inhaler effectively.

  3. C

    Use a long-acting bronchodilator as the initial rescue treatment.

  4. D

    Use intravenous magnesium sulfate routinely for every exacerbation.

08
Choose all
1 point

Select all appropriate monitoring considerations for a patient receiving a short-acting β₂-agonist during an acute exacerbation.

  1. A

    Monitor symptom relief, respiratory rate, work of breathing, and oxygen saturation.

  2. B

    Use ECG and potassium testing as mandatory routine monitoring for every patient receiving any dose.

  3. C

    When feasible, monitor PEF or FEV₁.

  4. D

    With frequent or high-dose therapy, assess heart rate and consider ECG and potassium; consider lactate if unexplained acidosis or persistent tachypnea occurs.

  5. E

    Monitor only for urinary retention and eye pain.

09
True or false
1 point

Repeated high doses of short-acting β₂-agonists can lower serum potassium, and high-dose treatment can raise lactate.

  1. A

    True

  2. B

    False

10
Written response
1 point

Which serum electrolyte can be lowered by repeated high doses of short-acting β₂-agonists?

11
Fill in the blank
1 point

stimulate β₂-adrenergic receptors in airway smooth muscle and increase cyclic AMP.

12
Choose one
1 point

How do short-acting β₂-agonists act to relieve bronchospasm?

  1. A

    They block muscarinic receptors and reduce airway secretions.

  2. B

    They stimulate β₂-adrenergic receptors, increase cyclic AMP, and relax airway smooth muscle.

  3. C

    They activate glucocorticoid receptors and suppress airway inflammation.

  4. D

    They block β₂-adrenergic receptors and tighten airway smooth muscle.

13
True or false
1 point

True or false: Repeated high doses of short-acting β₂-agonists can lower serum potassium.

  1. A

    True

  2. B

    False

14
Written response
1 point

Which inhaled device may be useful when a patient cannot use an inhaler effectively?

15
Choose one
1 point

A patient with an acute COPD exacerbation cannot use an inhaler effectively. Which inhaled delivery approach is supported for a short-acting β₂-agonist?

  1. A

    Use a nebulizer when the patient cannot use an inhaler effectively.

  2. B

    Use an oral tablet because inhaled delivery is not recommended.

  3. C

    Use a long-acting bronchodilator as the initial rescue treatment.

  4. D

    Avoid a spacer because it prevents rapid inhaled delivery.

16
Written response
1 point

Which common dose-related adverse effect of short-acting β₂-agonists is an abnormally fast heart rate?

17
Choose one
1 point

For a patient receiving frequent or high-dose short-acting β₂-agonist therapy, which additional monitoring is supported?

  1. A

    Monitor only blood glucose and mood.

  2. B

    Monitor urinary symptoms and eye pain.

  3. C

    Assess heart rate and consider ECG and serum potassium.

  4. D

    Monitor reflexes and blood pressure as the specific routine for β₂-agonists.

18
Choose one
1 point

Which statement best describes the role of short-acting β₂-agonists in acute asthma and COPD exacerbations?

  1. A

    They are maintenance-only drugs and are not used as initial bronchodilators in COPD exacerbations.

  2. B

    They rapidly relieve bronchospasm, are first-line relievers in acute asthma, and are initial bronchodilators in COPD exacerbations.

  3. C

    They work primarily by suppressing airway inflammation, with delayed benefit.

  4. D

    They must be used alone and cannot be combined with systemic corticosteroids when indicated.

19
Choose one
1 point

How do short-acting β₂-agonists such as albuterol produce bronchodilation?

  1. A

    They block muscarinic receptors, reducing vagal bronchoconstriction.

  2. B

    They stimulate β₂-adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscle.

  3. C

    They activate glucocorticoid receptors and suppress airway inflammation.

  4. D

    They inhibit airway secretions by blocking histamine receptors.

20
Choose one
1 point

A patient with an acute asthma exacerbation cannot use an inhaler effectively. Which approach is supported for delivering a short-acting β₂-agonist?

  1. A

    Use an oral β₂-agonist because inhaled delivery is unsuitable during an exacerbation.

  2. B

    Use a long-acting bronchodilator as the initial rescue treatment.

  3. C

    Consider a nebulizer if the patient cannot use an inhaler effectively.

  4. D

    Avoid bronchodilators until the patient can perform peak flow measurements.